THE WHAT? Fashion and beauty retailer Nordstrom has reported a Q4 net sales increase of 23 percent versus the same period in fiscal 2020 and a 1 percent decrease versus the same period in fiscal 2019.
THE DETAILS Net earnings reached US$200 million with earnings before interest and taxes (EBIT) of US$299 million, or 6.8 percent of sales for Q4.
Sales in beauty, active, designer and kids had the strongest growth compared to Q4 2019, with Nordstrom banner sales in the Southern markets, including Southern California, outperforming the Northern markets by approximately 7 percentage points.
THE WHY? According to Nordstrom, it continued to navigate global supply chain disruptions throughout the quarter by accelerating receipts and investing in improved in-stock levels.
Inventory levels at the end of the quarter were higher than planned, however, Nordstrom expects to reduce its inventory relative to sales during the first quarter of fiscal 2022.
Erik Nordstrom, Chief Executive Officer of Nordstrom, said, “We advanced our strategic initiatives this quarter, with sequential sales improvement, strong digital growth and a significant increase in profitability.
“Our team continues to work with urgency to accelerate our progress and invest in our capabilities to better serve customers and profitably grow sales. Our primary focus is on three areas: improving Nordstrom Rack performance, increasing profitability and optimizing our supply chain and inventory flow. Our progress has given us line of sight to achieve in the coming year the financial targets we presented at our 2021 Investor Event.”
Aesthetic injectable companies refer to businesses or companies that specialize in manufacturing, distributing, or providing aesthetic injectable products and services. These companies focus on developing and supplying injectable substances used for cosmetic purposes, typically administered by qualified medical professionals. Aesthetic injectable companies play a crucial role in the field of aesthetic medicine and cosmetic dermatology by offering a variety of injectable products designed to enhance facial features, reduce wrinkles, and improve overall skin appearance.
Key aspects of aesthetic injectable companies include:
-
Product Development: These companies research, develop, and manufacture aesthetic injectables such as dermal fillers, botulinum toxins (e.g., Botox), collagen stimulators, and other specialized formulations. They often innovate new products to meet evolving market demands and technological advancements.
-
Distribution and Sales: Aesthetic injectable companies distribute their products through authorized channels, including healthcare providers, medical spas, and aesthetic clinics. They may also sell directly to licensed professionals who administer these treatments.
-
Regulatory Compliance: Due to the medical nature of their products, aesthetic injectable companies adhere to strict regulatory guidelines and obtain necessary approvals from health authorities (e.g., FDA in the United States) to ensure safety, efficacy, and quality standards.
-
Training and Support: Many companies provide training and educational support to healthcare professionals on the proper use, administration techniques, and safety protocols associated with their injectable products. This ensures that practitioners can deliver treatments effectively and safely.
-
Customer Support: Aesthetic injectable companies offer customer support services to healthcare providers and consumers, addressing inquiries, providing product information, and assisting with product usage and troubleshooting.
